All in Health
Ruth Garde is the creative producer behind Cut+Paste a hands-on exhibition at the Francis Crick Institute that aims to explore the ethical issues around gene editing and gather the public’s views about how this technology should be used.
Robin Lovell-Badge discusses why genome editing regulations and ethical approval decisions should not be left up to scientists alone.
Professor Yanick Crow and his team at the MRC Human Genetics Unit are testing new treatments for a rare genetic disorder called Aicardi–Goutières syndrome, or AGS.
Natalie Frankish from Genetic Alliance UK explains the long route to diagnosis for patients with rare genetic diseases and what a good diagnosis should look like.
Dr Joe Marsh at the MR Human Genetics Unit is trying to figure out how variations in the genome might cause disease.
Professor Zosia Miedzybrodzka from the University of Aberdeen explains how testing for rare genetic diseases has changed over the years, and where it’s heading in the future.
Dr Rachel Freathy and her team at the University of Exeter are looking at the correlation between birthweight and the risk of developing diabetes later in life.
Dr Courtney Hanna and her team at the University of Cambridge are investigating the epigenetic changes that influence the growth and development of the placenta - a vital but poorly understood organ.
Professor Dave Grattan and his team at the University of Otago are investigating the multifaceted role of the hormone prolactin in pregnancy.
While it might not be as dramatic a superpower as being able to live four kilometres up a freezing mountain, the ability of many humans to drink milk in adulthood is certainly handy. As the story goes, the spread of this gene through populations in some parts of the world coincided with the rise in dairy farming. In turn, this enabled people to get more protein and fat in their diets, grow healthy and strong, and outcompete the non-milk drinking populations around them. But the latest research suggests that this neat evolutionary Just So story may not be true.
Where does our personality come from? Obviously our brains have a lot to do with it, but is it genetic differences in our brains that lead to differences in how we think? Is it all in our upbringing and childhood experiences? Or is it something else? To tackle this question, we sit down with Kevin Mitchell, an Associate Professor of Genetics and Neuroscience at Trinity College Dublin and author of the book Innate: How the wiring of our brains shapes who we are.
Dr Sally Le Page chats with cardiologist Dr Rohin Francis, from the YouTube channel MedLife Crisis, about the groundbreaking operation this year transplanting a genetically modified pig heart into a human, and the ethics of such a procedure.
Dr Kat Arney chats with Professor Angelika Schnieke from the Technical University of Munich about how we create genetically modified pigs suitable for producing organ transplants for humans, and how we can avoid getting more than we bargained for from pigs.
By targeting drugs directly to tumours, exosome therapies can reduce side effects from cancer treatment
Exosomes are exciting treatments of the future - but how are they made?
Once thought to be little more than ‘dust’, exosomes are tiny biological mailbags that travel around the body.
Presenter Kat Arney tells the story of how biomathematician Kristin Swanson discovered that cancer cells with XX chromosomes behave differently to cancer cells with XY chromosomes.
